Atlas Trials

A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy

Clinical trial NCT04258956 · COMPLETED

Trial details

NCT number
NCT04258956
Sponsor
Maria Sklodowska-Curie National Research Institute of Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastrointestinal Stromal Tumors
Start date
2019-04-30
Primary completion
2021-04-30
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.